 |
인쇄하기
취소
|
Wooshin Medix wins patent disputes over risedronate sodium
Wooshin Medix has been making major strides by successfully winning patent disputes on risedronate sodium, which has been imported from Poland based Polpharma Co.
Wooshin is going on step further in securing its key import businesses after the Korean Intellectual Property Tribunal ruled in favor of Wooshin on April 30 in a patent dispute with Procter & Gamble.
The KIPT said Polpharma’s ri...
Wooshin is going on step further in securing its key import businesses after the Korean Intellectual Property Tribunal ruled in favor of Wooshin on April 30 in a patent dispute with Procter & Gamble.
The KIPT said Polpharma’s ri...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.